CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Bionano Genomics, Inc. - BNGO CFD

2.8589
5.61%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.1122
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02354 %
Charges from full value of position ($-4.47)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02354%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001318 %
Charges from full value of position ($0.25)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001318%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.001
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 3.0289
Open 3.0289
1-Year Change 188.47%
Day's Range 2.8189 - 3.0489
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2025 2.8589 -0.2000 -6.54% 3.0589 3.0589 2.8189
Mar 27, 2025 3.0289 -0.0800 -2.57% 3.1089 3.1489 3.0089
Mar 26, 2025 3.0889 -0.1700 -5.22% 3.2589 3.2889 2.9989
Mar 25, 2025 3.2489 0.0200 0.62% 3.2289 3.3589 3.2289
Mar 24, 2025 3.2489 0.0300 0.93% 3.2189 3.3689 3.2189
Mar 21, 2025 3.2089 0.0700 2.23% 3.1389 3.2789 3.1089
Mar 20, 2025 3.2089 -0.0100 -0.31% 3.2189 3.2889 3.1489
Mar 19, 2025 3.2289 0.0100 0.31% 3.2189 3.3589 3.2189
Mar 18, 2025 3.2389 -0.1500 -4.43% 3.3889 3.3889 3.2289
Mar 17, 2025 3.4089 -0.0500 -1.45% 3.4589 3.5089 3.3989
Mar 14, 2025 3.4189 0.1700 5.23% 3.2489 3.5389 3.2489
Mar 13, 2025 3.2689 -0.2200 -6.31% 3.4889 3.6089 3.2589
Mar 12, 2025 3.5889 -0.1600 -4.27% 3.7489 3.7489 3.5689
Mar 11, 2025 3.5689 -0.0100 -0.28% 3.5789 3.7089 3.4089
Mar 10, 2025 3.6489 -0.3300 -8.29% 3.9789 3.9989 3.6289
Mar 7, 2025 4.0489 0.0200 0.50% 4.0289 4.1989 3.9989
Mar 6, 2025 4.0289 0.0700 1.77% 3.9589 4.1389 3.9589
Mar 5, 2025 4.0289 0.1600 4.14% 3.8689 4.1889 3.7089
Mar 4, 2025 3.9389 0.1600 4.23% 3.7789 4.0189 3.6489
Mar 3, 2025 3.9289 -0.2700 -6.43% 4.1989 4.2389 3.9089

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Bionano Genomics, Inc. Company profile

Bionano Genomics (BNGO) is a provider of solutions for genome analysis. Additionally, the company offers diagnostic services, software and optical genome mapping solutions for basic, translational and clinical research applications.

Based in San Diego, California, the company has two businesses: Lineagen and BioDiscovery.

Lineagen provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental impairments.

Through BioDiscovery, the company also offers an industry-leading, platform-diagnostic software solution. Integrating next-generation sequencing and microarray data to analyse, visualise, interpret, and report copy number variants, single-nucleotide variants, and the absence of heterozygosity across the genome in a single consolidated view. 

In October 2021, Bionano Genomics bought Biodiscovery, a software company that provides solutions for analysing, interpreting and reporting genomics data.

The acquisition is expected to accelerate the adoption of optical genome mapping (OGM), with the integration of BioDiscovery's NxClinical software solution. Saphyr System is Bionano’s featured product for OGM.

Saphyr is an ultra-sensitive genome analysis platform that can detect structural variations for mosaic samples or heterogeneous cancer samples with a false positive rate of less than 2%.

The company, founded in 2003, sells its products for research use in laboratories associated with academic and governmental research institutions. For North America and Europe, Bionano sells its products through a direct sales force. It also sells its products via third party distributors in China, Japan, South Korea, Singapore, Australia, India and South Africa. 

Bionano became a public company in September 2018. Its shares are traded on the Nasdaq under the ticker symbol BNGO.

Industry: Advanced Medical Equipment & Technology (NEC)

9640 Towne Centre Drive
9640 Towne Centre Drive
SAN DIEGO
CALIFORNIA 92121
US

People also watch

US100

19,177.30 Price
-3.190% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

83,690.55 Price
-0.070% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

ETH/USD

1,878.00 Price
+0.160% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 1.75

XRP/USD

2.12 Price
-2.610% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01058

Still looking for a broker you can trust?

Join the 710,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading